Sanjivani Paranteral Ltd's Stock Reaches 52-Week High, Outperforms Sector by 1.47%

Aug 19 2024 09:45 AM IST
share
Share Via
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has been making headlines in the stock market with its recent performance. On August 19, 2024, the company's stock price reached a 52-week high of Rs. 282.85, outperforming the sector by 1.47%. This marks a consecutive gain for the last 3 days, with a 6.27% increase in returns during this period. Despite a slight loss today, the stock has been trading above its moving averages, indicating a positive trend in the short and long term. With a remarkable performance of 248.58% in the past year, Sanjivani Paranteral has shown strong growth potential and has outperformed the market. While MarketsMojo has given a 'Sell' call for the stock, this is not a recommendation from experts or investors, but a fact-based analysis of its performance. As a microcap company in the pharmaceutical industry, Sanjivani Paranteral is definitely one to watch in the stock market.

Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has been making waves in the stock market with its recent performance. On August 19, 2024, the company's stock price reached a 52-week high of Rs. 282.85, outperforming the sector by 1.47%. This marks a consecutive gain for the last 3 days, with a 6.27% increase in returns during this period.

Despite opening with a loss of -2.05% today, Sanjivani Paranteral's stock has been trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock in the short and long term.

In the past year, Sanjivani Paranteral has shown an impressive performance of 248.58%, compared to the Sensex's 24.13% performance. This highlights the company's strong growth potential and its ability to outperform the market.

MarketsMOJO has given a 'Sell' call for Sanjivani Paranteral's stock, suggesting that investors should consider selling their shares. However, it is important to note that this is not a recommendation from experts or investors, but rather a fact-based analysis of the stock's performance.

As a microcap company in the pharmaceutical industry, Sanjivani Paranteral has shown promising growth and potential. With its recent 52-week high and strong performance in the past year, the company is definitely one to watch in the stock market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Sanjiv.Parant. falling/rising?
Dec 10 2025 12:24 AM IST
share
Share Via
Is Sanjiv.Parant. overvalued or undervalued?
Nov 18 2025 08:18 AM IST
share
Share Via
Why is Sanjiv.Parant. falling/rising?
Nov 17 2025 09:23 PM IST
share
Share Via
Sanjivani Paranteral Hits New 52-Week Low at Rs. 170
Nov 17 2025 10:59 AM IST
share
Share Via
Sanjivani Paranteral Hits New 52-Week Low at Rs. 170
Nov 17 2025 10:59 AM IST
share
Share Via